Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
SAR-20347 inhibits TYK2- and JAK1-mediated IL-12 and IFN-α signaling
Pipofezine(Azafen or Azaphen) is a potent inhibitor of the reuptake of serotonin
OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C21
Molecular Weight: 649
Canagliflozin - CAS# 842133-18-0 Catalog No.:M10730-10 SAR-20347 inhibits TYK2- and JAK1-mediatedCanagliflozin (INN, trade name Invokana) is a drug for the treatment of type 2 diabetes. It was developed by Mitsubishi Tanabe Pharma and is marketed under license by Janssen, a division of Johnson & Johnson. Canagliflozin is an inhibitor of subtype 2 sodium glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the
US$ 125.00
US$ 2825.00
US$ 912.50
US$ 29.99
US$ 112.50
US$ 2353.00